This site provides information on the EPIC study and details on case recruitment for veterinary professionals worldwide. Pimobendan is a prescription only medicine, licensed for the treatment of congestive heart failure due to mitral valve disease or dilated cardiomyopathy.

The EPIC Trial site is intended for veterinary professionals. By clicking 'Continue' you are affirming that you are a veterinary professional.

Evaluating Pimobendan in Cardiomegaly
Media & Journalists  •  Contact  •  Helpful Links  •  FAQs  •  Site Map

Trial Locations

EPIC is the largest prospective cardiology study ever conducted in dogs.

Veterinarians in 11 countries, from every region of the world, have been recruited to participate in EPIC.

Clinical investigations will be conducted at 36 trial centers throughout the world. Click on a nation below to find the center nearest you.


Investigator Sign in

Investigators, please sign in here.